Nektar Therapeutics (NKTR) Reports In-Line Q2 EPS

Go back to Nektar Therapeutics (NKTR) Reports In-Line Q2 EPS
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 75.50 --0 (-0%)
Previous Close $75.50    52 Week High $19.98 
Open $75.50    52 Week Low $10.52 
Day High $75.50    P/E N/A 
Day Low $75.50    EPS $-1.45 
Volume 111